Search Results 411-420 of 14891 for testosterone

  1. Mayo Clinic Child and Family Advocacy Center Will Hold an Open House April 22

    NOTE: Members of the media should RSVP to Kelley Luckstein at 507-284-5005. Tuesday Q & A: Mildly low level of testosterone typically doesn't require treatment.

  2. Mayo Clinic Q and A: Genetics and weight

    Low testosterone in women: Mayo Clinic Radio Health Minute · Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic ...

  3. Publications - C. Burcin Taner, M.D. - Mayo Clinic

    Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy. ACG Case Rep J. 2024 Sep; 11 (9):e01483 Epub 2024 Sept 11. View PubMed ...

  4. Mayo Clinic Comprehensive Cancer Center — Research

    Abiraterone acetate may help fight prostate cancer by lowering the amount of testosterone made by the body. Apalutamide may help fight prostate cancer by ...

  5. Masculinizing surgery - Mayo Clinic

    Find out how masculinizing surgical procedures can help better align the body with a person's gender identity.

  6. Mayo Clinic Q and A: Turmeric for healthier diet, pain relief

    Turmeric is becoming a common spice in many home pantries, especially since people are hearing of its many purported health effects, including reducing ...

  7. Male masturbation: Does frequency affect male fertility? - Mayo Clinic

    Some data shows that optimum semen quality occurs after two to three days of no ejaculation. But other research suggests that men who have normal sperm quality ...

  8. Insulin Detemir (Subcutaneous Route) Before Using - Mayo Clinic

    Testosterone; Thioctic Acid; Tolazamide; Tolbutamide; Triamterene; Trovafloxacin; Vildagliptin. Using this medicine with any of the following medicines may ...

  9. Paclitaxel Protein-Bound (Intravenous Route) Before Using - Mayo Clinic

    Testosterone; Tretinoin; Typhoid Vaccine, Live; Yellow Fever Vaccine. Other Interactions. Certain medicines should not be used at or around the time of eating ...

  10. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    - Surgical or medical castration, with serum testosterone ≤ 50 ng/dL (≤ 1.73 nmol/L) at screening - Measurable (extrapelvic soft tissue) metastatic ...